Nanalysis Scientific Corp (OTCPK:NSCIF)

$ 0.2505 -0.0119 (-4.54%) Market Cap: 28.95 Mil Enterprise Value: 42.07 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 46/100

Q2 2024 Nanalysis Scientific Corp Earnings Call Transcript
Aug 28, 2024

$0.29485 (+0.26%)

Earnings
Q1 2024 Nanalysis Scientific Corp Earnings Call Transcript
May 29, 2024

$0.3233 (+1.54%)

Earnings
Q4 2023 Nanalysis Scientific Corp Earnings Call Transcript
Apr 29, 2024

$0.3256 (-1.63%)

Earnings
Q2 2023 Nanalysis Scientific Corp. Earnings Call Transcript
Aug 24, 2023

$0.38

Earnings
Nanalysis Scientific Corp. at LD Micro Invitational Conference Transcript
Jun 06, 2023
Q1 2023 Nanalysis Scientific Corp. Earnings Call Transcript
May 25, 2023

$0.4356 (+1.82%)

Earnings
Q4 2022 Nanalysis Scientific Corp. Earnings Call Transcript
Apr 27, 2023

$0.4645 (+5.36%)

Earnings
Q3 2022 Nanalysis Scientific Corp. Earnings Call - Q&A Session Transcript
Nov 30, 2022

$0.517 (-8.50%)

Earnings
Q3 2022 Nanalysis Scientific Corp. Earnings Call Transcript
Nov 29, 2022

$0.565 (+0.89%)

Earnings
Nanalysis Scientific Corp. at OTC Markets International Virtual Investor Conference Transcript
Jun 16, 2022
Nanalysis Scientific Corp at Noble Capital Markets Investor Conference (Virtual) Transcript
Apr 20, 2022
Nanalysis Scientific Corp at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 08, 2022
Nanalysis Scientific Corp at SNN Network Canada Virtual Event Transcript
Dec 08, 2021
Nanalysis Scientific Corp Deep Dive Presentation with CEO Sean Krakiwsky & CFO Luke Caplette Transcript
Oct 20, 2021
Nanalysis Scientific Corp at LD Micro Microcap Invitational Conference (Virtual) Transcript
Jun 08, 2021

Nanalysis Scientific Corp at Noble Capital Markets Investor Conference (Virtual) Transcript

Apr 20, 2022 / 04:30PM GMT

Release Date Price: $0.99 (+0.42%)

Transcript

Sean Krakiwsky

Nanalysis Scientific Corp. - President & CEO, Founder

Good afternoon, everyone. I'm Sean Krakiwsky; I'm the CEO and Founder of Nanalysis Scientific Corp. We make portable NMR and MRI machines for industrial and healthcare applications. We do seek Safe Harbor for forward-looking statements.

Where we're trading at today, we have a market cap of about $100 million. We are a revenue-generating company, so we've stated publicly that we did approximately $16 million in revenue in 2021. We've also stated publicly that our revenue target for 2022 is $35 million or more, so not one of these tech companies that's sort of burning boatloads of cash. We are EBITDA positive. We have plenty of cash on our balance sheet, and we have some exciting milestones in the next year and beyond.

So I founded the business about 12 years ago, and it's just been a fabulous journey. I'll talk a little bit more about that as we get through this. We have a fabulous management team, including an incredibly talented and experienced CFO; and our CTO, Julien Muller, has a really unique vision for the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.